2m 2m 2m 2m 2m 2m 2m
TONIX PHARM HLD (TNXP)
NASDAQ
$11.38-$0.03 (-0.22%)
Price as of Jun 03, 2026 7:45 PM EDT- $196.6MMarket Cap
- -70.73%1-Year Change
- BiotechnologyIndustry
TONIX PHARM HLD (TNXP)
$11.38-$0.03 (-0.22%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 13.1M +53.37% | 8.5M +10.02% | 7.8M N/A | N/A N/A | |
Cost of Revenue | 6.6M -14.49% | 7.8M +63.78% | 4.7M N/A | N/A N/A | |
Gross Profit | 6.5M +728.04% | 781,000 -74.20% | 3.0M N/A | 0 N/A | |
Sales and Marketing Expense | 87.7M +118.66% | 40.1M +15.39% | 34.8M N/A | N/A N/A | |
Research and Development Expense | -44.5M +11.29% | -40.0M -53.87% | -86.7M +5.84% | -81.9M +18.94% | |
Depreciation and Amortization Expense | 1.9M -43.73% | 3.4M -20.27% | 4.3M +242.46% | 1.3M +2,406.00% | |
Total Operating Expenses | 138.8M -5.44% | 146.8M +16.37% | 126.1M +12.54% | 112.1M +21.43% | |
Operating Profit | -125.7M -8.05% | -136.7M +15.48% | -118.4M +5.61% | -112.1M +21.43% | |
Interest Income | 4.1M N/A | N/A N/A | 1.7M -8.06% | 1.9M +7,392.00% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 4.1M N/A | 0 -100.00% | 1.7M -8.06% | 1.9M +7,392.00% | |
Total Nonoperating Income and Expense | -3.3M +58.49% | -2.1M N/A | N/A N/A | N/A N/A | |
Income before Taxes | -124.0M -4.63% | -130.0M +11.47% | -116.7M -0.19% | -116.9M +26.65% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | 59.0M N/A | N/A N/A | N/A N/A | |
Net Income | -124.0M -4.63% | -130.0M +11.47% | -116.7M +5.84% | -110.2M +19.43% | |
Net Income from Continuing Operations Applicable to Common | -124.0M -4.63% | -130.0M +11.47% | -116.7M -0.19% | -116.9M +26.65% | |
Basic EPS and Net Income | -14.57 -91.75% | -176.60 +2,478.10% | -6.85 +109.48% | -3.27 +1,157.69% | |
Diluted EPS and Net Income | -14.57 -91.75% | -176.60 +2,478.10% | -6.85 +109.48% | -3.27 +1,157.69% | |
Basic Weighted Average Shares | 8.5M +1,055.90% | 736,339 -95.68% | 17.0M -52.32% | 35.7M -90.08% | |
Diluted Weighted Average Shares | 8.5M +1,055.90% | 736,339 -95.68% | 17.0M -52.32% | 35.7M -90.08% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 207.6M +110.21% | 98.8M +295.93% | 24.9M -79.25% | 120.2M -32.71% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 207.6M +110.21% | 98.8M +295.93% | 24.9M -79.25% | 120.2M -32.71% | |
Total Current Assets | 228.9M +92.33% | 119.0M +149.12% | 47.8M -63.47% | 130.8M -30.82% | |
Accumulated Depreciation | 6.0M +46.99% | 4.1M -23.59% | 5.4M +224.38% | 1.7M +313.25% | |
Property and Plant and Equipment and Net | 44.5M +5.22% | 42.3M -55.06% | 94.0M +0.23% | 93.8M +85.56% | |
Total Long-Term Assets | 2.2M +128.71% | 951,000 -15.77% | 1.1M +194.01% | 384,000 -99.24% | |
Total Assets | 277.2M +70.16% | 162.9M +5.46% | 154.5M -31.56% | 225.7M -6.31% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 2.8M +20.00% | 2.4M N/A | N/A N/A | |
Total Current Liabilities | 30.8M +68.44% | 18.3M -3.06% | 18.9M +3.87% | 18.2M -16.28% | |
Total Long-Term Debt | N/A N/A | 4.7M -28.87% | 6.6M N/A | N/A N/A | |
Total Long-Term Liabilities | 1.2M -76.44% | 5.0M -83.08% | 29.7M +8,952.74% | 328,000 -29.76% | |
Total Liabilities | 32.0M +37.24% | 23.3M -52.32% | 48.9M +164.38% | 18.5M -16.57% | |
Retained Earnings | -854.7M +16.97% | -730.7M +21.65% | -600.7M +27.79% | -470.0M +30.63% | |
Total Stockholders Equity | 245.2M +75.66% | 139.6M +32.25% | 105.5M -49.07% | 207.2M -5.27% | |
Total Shares Outstanding | 12.8M +128.74% | 5.6M -90.46% | 58.6M -23.36% | 76.5M -84.59% | |
Cash Flow | |||||
Cash from Operating Activities | -99.8M +63.88% | -60.9M -40.27% | -102.0M +4.03% | -98.1M +29.77% | |
Capital Expenditures | 3.4M +2,707.50% | 120,000 -98.48% | 7.9M -83.60% | 48.1M +36.37% | |
Cash from Investing Activities | -4.5M +3,673.33% | -120,000 -99.59% | -29.1M -39.62% | -48.1M +36.37% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 214.5M +59.06% | 134.9M +269.34% | 36.5M -58.43% | 87.8M -58.66% | |
Financials Ratio | |||||
Gross Margin | 49.34% +439.90% | 9.14% -76.55% | 38.97% N/A | N/A N/A | |
Operating Margin | -959.05% -40.04% | -1,599.59% +4.96% | -1,523.94% N/A | N/A N/A | |
Return on Assets | -56.37% -31.22% | -81.95% +33.53% | -61.38% +29.91% | -47.24% -13.21% | |
Return on Equity | -64.48% -39.24% | -106.12% +42.22% | -74.61% +44.16% | -51.76% -14.09% | |
Revenue Growth | 53.37% +432.88% | 10.02% N/A | N/A N/A | N/A N/A | |
Current Ratio | 7.42 +14.18% | 6.50 +156.98% | 2.53 -64.84% | 7.19 -17.37% | |
Cash Ratio | 6.73 +24.80% | 5.40 +308.41% | 1.32 -80.02% | 6.61 -19.62% | |
Debt-to-Equity Ratio | N/A N/A | 0.05 -36.49% | 0.08 N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | 0.05 -20.28% | 0.06 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow